Evaluating Malaria Rapid Diagnostic Tests and Microscopy for Detecting Plasmodium Infection and Status of Plasmodium falciparum Histidine-Rich Protein 2/3 Gene Deletions in Southeastern Nigeria
- PMID: 38531105
- PMCID: PMC11066366
- DOI: 10.4269/ajtmh.23-0690
Evaluating Malaria Rapid Diagnostic Tests and Microscopy for Detecting Plasmodium Infection and Status of Plasmodium falciparum Histidine-Rich Protein 2/3 Gene Deletions in Southeastern Nigeria
Abstract
Delays in malaria diagnosis increase treatment failures and deaths. In endemic regions, standard diagnostic methods are microscopy and malaria rapid diagnostic tests (mRDTs) detecting Plasmodium falciparum histidine-rich protein 2/3 (PFHRP2/PFHRP3), but gene deletions can allow certain parasites to remain undetected. We enlisted a cohort comprising 207 symptomatic individuals, encompassing both children and adults, at a hospital in Nnewi, Nigeria. The prevalence of parasites was determined using a highly sensitive, species-specific quantitative polymerase chain reaction (SS-qPCR). Within a subset of 132 participants, we assessed the sensitivity and specificity of microscopy and HRP2-mRDTs in comparison to SS-qPCR for the detection of P. falciparum. We also investigated the prevalence of pfhrp2/pfhrp3 gene deletions. Greater sensitivity was achieved with mRDTs (95%) compared with microscopy (77%). Also, mRDTs exhibited greater specificity (68%) than microscopy (44%). The positive predictive value of mRDTs (89%) surpassed that of microscopy (80%), suggesting a greater probability of accurately indicating the presence of infection. The negative predictive value of mRDTs (82%) was far greater than microscopy (39%). Of the 165 P. falciparum-positive samples screened for pfhrp2/pfhrp3 gene deletions, one gene deletion was detected in one sample. Regarding infection prevalence, 84% were positive for Plasmodium spp. (by reverse transcription [RT]-qPCR), with P. falciparum responsible for the majority (97%) of positive cases. Thus, exclusive reliance on microscopy in endemic areas may impede control efforts resulting from false negatives, underscoring the necessity for enhanced training and advocating for high-throughput molecular testing such as RT-qPCR or qPCR at referral centers to address limitations.
Conflict of interest statement
Disclosure: The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study received ethical approval from the Ethics Review Board, Nnamdi Azikiwe University Teaching Hospital, Nnewi, southeastern Nigeria (approval no. NAUTH/CS/66/Vol.11/185/2018/118). Written informed consent was obtained from participants or parents/guardians of all participating children.
Figures






Similar articles
-
pfhrp2 and pfhrp3 Gene Deletions That Affect Malaria Rapid Diagnostic Tests for Plasmodium falciparum: Analysis of Archived Blood Samples From 3 African Countries.J Infect Dis. 2019 Sep 26;220(9):1444-1452. doi: 10.1093/infdis/jiz335. J Infect Dis. 2019. PMID: 31249999 Free PMC article.
-
Histidine-rich protein (hrp) 2-based RDT false-negatives and Plasmodium falciparum hrp 2 and 3 gene deletions in low, seasonal and intense perennial transmission zones in Cameroon: a cross - sectional study.BMC Infect Dis. 2024 Sep 30;24(1):1080. doi: 10.1186/s12879-024-09935-4. BMC Infect Dis. 2024. PMID: 39350071 Free PMC article.
-
Molecular surveillance of pfhrp2 and pfhrp3 genes deletion in Plasmodium falciparum isolates and the implications for rapid diagnostic tests in Nigeria.Acta Trop. 2019 Aug;196:121-125. doi: 10.1016/j.actatropica.2019.05.016. Epub 2019 May 16. Acta Trop. 2019. PMID: 31103699
-
Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum malaria.Clin Microbiol Infect. 2019 May;25(5):580-585. doi: 10.1016/j.cmi.2018.09.009. Epub 2018 Sep 27. Clin Microbiol Infect. 2019. PMID: 30267926 Review.
-
Force Protection Risks in AFRICOM, INDOPACOM and SOUTHCOM Due to Rapid Diagnostic Test Failures for Falciparum Malaria, 2016-2022.MSMR. 2023 Oct 1;30(10):7-11. MSMR. 2023. PMID: 37963222 Review.
References
-
- World Health Organization , 2022. World Malaria Report 2022. Geneva, Switzerland: WHO.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous